Literature DB >> 27509488

Diversity of Human and Macaque Airway Immune Cells at Baseline and during Tuberculosis Infection.

Richard F Silver1,2,3, Amy J Myers4, Jessica Jarvela1, JoAnne Flynn4, Tara Rutledge5, Tracey Bonfield6, Philana Ling Lin5.   

Abstract

Immune cells of the distal airways serve as "first responders" of host immunity to the airborne pathogen Mycobacterium tuberculosis (Mtb). Mtb infection of cynomolgus macaques recapitulates the range of human outcomes from clinically silent latent tuberculosis infection (LTBI) to active tuberculosis of various degrees of severity. To further advance the application of this model to human studies, we compared profiles of bronchoalveolar lavage (BAL) cells of humans and cynomolgus macaques before and after Mtb infection. A simple gating strategy effectively defined BAL T-cell and phagocyte populations in both species. BAL from Mtb-naive humans and macaques showed similar differential cell counts. BAL T cells of macaques were composed of fewer CD4+cells but more CD8+ and CD4+CD8+ double-positive cells than were BAL T cells of humans. The most common mononuclear phagocyte population in BAL of both species displayed coexpression of HLA-DR, CD206, CD11b, and CD11c; however, multiple phagocyte subsets displaying only some of these markers were observed as well. Macaques with LTBI displayed a marked BAL lymphocytosis that was not observed in humans with LTBI. In macaques, the prevalence of specific mononuclear phagocyte subsets in baseline BAL correlated with ultimate outcomes of Mtb infection (i.e., LTBI versus active disease). Overall, these findings demonstrate the comparability of studies of pulmonary immunity to Mtb in humans and macaques. They also indicate a previously undescribed complexity of airway mononuclear phagocyte populations that suggests further lines of investigation relevant to understanding the mechanisms of both protection from and susceptibility to the development of active tuberculosis within the lung.

Entities:  

Keywords:  alveolar macrophages; bronchoalveolar lavage; human subjects; macaques; tuberculosis

Mesh:

Substances:

Year:  2016        PMID: 27509488      PMCID: PMC5248955          DOI: 10.1165/rcmb.2016-0122OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  49 in total

1.  Long-term control of simian immunodeficiency virus (SIV) in cynomolgus macaques not associated with efficient SIV-specific CD8+ T-cell responses.

Authors:  Timothée Bruel; Chiraz Hamimi; Nathalie Dereuddre-Bosquet; Antonio Cosma; So Youn Shin; Aurélien Corneau; Pierre Versmisse; Ingrid Karlsson; Benoit Malleret; Brice Targat; Françoise Barré-Sinoussi; Roger Le Grand; Gianfranco Pancino; Asier Sáez-Cirión; Bruno Vaslin
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

2.  Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses.

Authors:  Murugesan V S Rajaram; Michelle N Brooks; Jessica D Morris; Jordi B Torrelles; Abul K Azad; Larry S Schlesinger
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

3.  PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis.

Authors:  M Teresa Coleman; Ray Y Chen; Myungsun Lee; Philana Ling Lin; Lori E Dodd; Pauline Maiello; Laura E Via; Youngran Kim; Gwendolyn Marriner; Veronique Dartois; Charles Scanga; Christopher Janssen; Jing Wang; Edwin Klein; Sang Nae Cho; Clifton E Barry; JoAnne L Flynn
Journal:  Sci Transl Med       Date:  2014-12-03       Impact factor: 17.956

Review 4.  CD36, a scavenger receptor involved in immunity, metabolism, angiogenesis, and behavior.

Authors:  Roy L Silverstein; Maria Febbraio
Journal:  Sci Signal       Date:  2009-05-26       Impact factor: 8.192

5.  Recruitment of antigen-specific Th1-like responses to the human lung following bronchoscopic segmental challenge with purified protein derivative of Mycobacterium tuberculosis.

Authors:  Richard F Silver; Lynn Zukowski; Susan Kotake; Qing Li; Fatima Pozuelo; Adriana Krywiak; Rhonda Larkin
Journal:  Am J Respir Cell Mol Biol       Date:  2003-07       Impact factor: 6.914

6.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

7.  (18)F-FDG positron-emission tomography/computed tomography findings of radiographic lesions suggesting old healed tuberculosis.

Authors:  Yun-Jeong Jeong; Jin Chul Paeng; Hyun-Yeol Nam; Ji Sun Lee; Sang-Min Lee; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Jae-Joon Yim
Journal:  J Korean Med Sci       Date:  2014-02-27       Impact factor: 2.153

Review 8.  Alveolar macrophages: plasticity in a tissue-specific context.

Authors:  Tracy Hussell; Thomas J Bell
Journal:  Nat Rev Immunol       Date:  2014-01-21       Impact factor: 53.106

Review 9.  Macrophage heterogeneity in respiratory diseases.

Authors:  Carian E Boorsma; Christina Draijer; Barbro N Melgert
Journal:  Mediators Inflamm       Date:  2013-02-27       Impact factor: 4.711

10.  PET CT Identifies Reactivation Risk in Cynomolgus Macaques with Latent M. tuberculosis.

Authors:  Philana Ling Lin; Pauline Maiello; Hannah P Gideon; M Teresa Coleman; Anthony M Cadena; Mark A Rodgers; Robert Gregg; Melanie O'Malley; Jaime Tomko; Daniel Fillmore; L James Frye; Tara Rutledge; Robert M DiFazio; Christopher Janssen; Edwin Klein; Peter L Andersen; Sarah M Fortune; JoAnne L Flynn
Journal:  PLoS Pathog       Date:  2016-07-05       Impact factor: 6.823

View more
  9 in total

1.  Pulmonary Mycobacterium tuberculosis control associates with CXCR3- and CCR6-expressing antigen-specific Th1 and Th17 cell recruitment.

Authors:  Uma Shanmugasundaram; Allison N Bucsan; Shashank R Ganatra; Chris Ibegbu; Melanie Quezada; Robert V Blair; Xavier Alvarez; Vijayakumar Velu; Deepak Kaushal; Jyothi Rengarajan
Journal:  JCI Insight       Date:  2020-07-23

Review 2.  Tuberculosis vaccines - perspectives from the NIH/NIAID Mycobacteria vaccine testing program.

Authors:  Angelo A Izzo
Journal:  Curr Opin Immunol       Date:  2017-07-24       Impact factor: 7.486

3.  Construction and analysis of the transcription factor-microRNA co-regulatory network response to Mycobacterium tuberculosis: a view from the blood.

Authors:  Yan Lin; Zipeng Duan; Feng Xu; Jiayuan Zhang; Marina V Shulgina; Fan Li
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

Review 4.  The End of the Binary Era: Revisiting the Spectrum of Tuberculosis.

Authors:  Philana Ling Lin; JoAnne L Flynn
Journal:  J Immunol       Date:  2018-11-01       Impact factor: 5.422

Review 5.  Neutrophils in Tuberculosis: Cell Biology, Cellular Networking and Multitasking in Host Defense.

Authors:  Rachana R Borkute; Sören Woelke; Gang Pei; Anca Dorhoi
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

6.  Toll-like receptor 2bright cells identify circulating monocytes in human and non-human primates.

Authors:  Erin N Shirk; Brian G Kral; Lucio Gama
Journal:  Cytometry A       Date:  2017-03-21       Impact factor: 4.355

Review 7.  Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges.

Authors:  Elena Stylianou; Matthew J Paul; Rajko Reljic; Helen McShane
Journal:  Expert Rev Vaccines       Date:  2019-12-26       Impact factor: 5.217

8.  Targeted Gene Expression Profiling of Human Myeloid Cells From Blood and Lung Compartments of Patients With Tuberculosis and Other Lung Diseases.

Authors:  Leigh Ann Kotze; Gian van der Spuy; Bryan Leonard; Adam Penn-Nicholson; Munyaradzi Musvosvi; Shirley McAnda; Stephanus T Malherbe; Mzwandile Erasmus; Thomas Scriba; Coenraad F N Koegelenberg; Brian W Allwood; Gerhard Walzl; Nelita du Plessis
Journal:  Front Immunol       Date:  2022-03-08       Impact factor: 7.561

Review 9.  Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis.

Authors:  Nelita du Plessis; Leigh A Kotze; Vinzeigh Leukes; Gerhard Walzl
Journal:  Front Cell Infect Microbiol       Date:  2018-09-21       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.